Oscar M. Rueda

25.0k citations

70 papers · 4.6k indexed · 2 hit papers · h-index 28

Cancer Research top 0.5%
Molecular Biology top 5%
Oncology top 1%
Pulmonary and Respiratory Medicine top 2%
Pathology and Forensic Medicine top 2%

Co-authors: Carlos Caldas Suet‐Feung Chin Sarah‐Jane Dawson Mark Dunning Samuel Aparício Tim Forshew Nitzan Rosenfeld Dana W.Y. Tsui
Topics: Cancer Genomics and Diagnostics (26 papers)Gene expression and cancer classification (18 papers)Genomic variations and chromosomal abnormalities (14 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: New England Journal of Medicine Nucleic Acids Research Nature Communications
Partner nations: United Kingdom Spain United States

In The Last Decade

Oscar M. Rueda

68 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

2013 1.6k citations Sarah‐Jane Dawson, Oscar M. Rueda et al. profile →
Breast tumor microenvironment structures are associated with genomic features and clinical outcome

2022 141 citations Helen Bardwell, Suet‐Feung Chin et al. profile →

Peers

Countries citing papers authored by Oscar M. Rueda

Since Specialization

Citations

This map shows the geographic impact of Oscar M. Rueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar M. Rueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar M. Rueda more than expected).

Fields of papers citing papers by Oscar M. Rueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar M. Rueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar M. Rueda. The network helps show where Oscar M. Rueda may publish in the future.

Co-authorship network of co-authors of Oscar M. Rueda

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar M. Rueda. A scholar is included among the top collaborators of Oscar M. Rueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar M. Rueda. Oscar M. Rueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fitness and transcriptional plasticity of human breast cancer single-cell-derived clones 2025 ·Cell Reports ·Long Nguyen,(unknown),(unknown),(unknown),Suet‐Feung Chin,(unknown),Stephen‐John Sammut,Giulia Lerda,(unknown),Helen Bardwell,Wendy Greenwood,Hyun Jin Shin,(unknown),Katarzyna Kania,Alejandra Bruna,(unknown),(unknown),Samuel Aparício,Oscar M. Rueda,Carlos Caldas	0
2	Development and validation of a reliable DNA copy-number-based machine learning algorithm (CopyClust) for breast cancer integrative cluster classification 2024 ·Scientific Reports ·Cameron C. Young,Katherine Eason,(unknown),(unknown),Sach Mukherjee,Suet‐Feung Chin,Carlos Caldas,Oscar M. Rueda	2
3	Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer 2024 ·npj Breast Cancer ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Siti Norhidayu Hasan,Tania Islam,Li‐Ying Teoh,Suniza Jamaris,Mee‐Hoong See,Cheng Har Yip,Pathmanathan Rajadurai,Lai‐Meng Looi,Nur Aishah Mohd Taib,Oscar M. Rueda,Carlos Caldas,Suet‐Feung Chin,Joanna Lim,Soo‐Hwang Teo	2
4	Predictability of B cell clonal persistence and immunosurveillance in breast cancer 2024 ·Nature Immunology ·Stephen‐John Sammut,Jacob D. Galson,Ralph Minter,Bo Sun,Suet‐Feung Chin,Leticia De Mattos‐Arruda,Donna K. Finch,Sebastian Schätzle,J.C. Dias,Oscar M. Rueda,Joan Seoane,Jane Osbourn,Carlos Caldas,Rachael Bashford-Rogers	10
5	Clustering of HR + /HER2− breast cancer in an Asian cohort is driven by immune phenotypes 2024 ·Breast Cancer Research ·(unknown),(unknown),(unknown),Siti Norhidayu Hasan,Tania Islam,Li‐Ying Teoh,Suniza Jamaris,Mee‐Hoong See,Cheng Har Yip,Pathmanathan Rajadurai,Lai‐Meng Looi,Nur Aishah Mohd Taib,Oscar M. Rueda,Carlos Caldas,Suet‐Feung Chin,Joanna Lim,Soo‐Hwang Teo	0
6	Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy 2022 ·British Journal of Cancer ·Tom van den Bosch,Oscar M. Rueda,Carlos Caldas,Louis Vermeulen,Daniël M. Miedema	2
7	NRG1 fusions in breast cancer 2021 ·Breast Cancer Research ·Karen Howarth,(unknown),Susanna L. Cooke,Suet‐Feung Chin,Jessica C. Pole,Ernest Turro,Matthew Eldridge,(unknown),Oscar M. Rueda,Chris Boursnell,Jean Abraham,Carlos Caldas,Paul A. Edwards	17
8	The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences 2020 ·Nature Communications ·(unknown),(unknown),(unknown),(unknown),Siti Norhidayu Hasan,(unknown),Stephen‐John Sammut,Cheng Har Yip,Pathmanathan Rajadurai,Oscar M. Rueda,Carlos Caldas,Suet‐Feung Chin,Soo‐Hwang Teo	52
9	Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53‐associated features 2020 ·Molecular Oncology ·(unknown),Garold Fuks,Suet‐Feung Chin,Oscar M. Rueda,Saptaparna Mukherjee,Sharathchandra Arandkar,Yael Aylon,Carlos Caldas,Eytan Domany,Moshe Oren	7
10	EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis 2019 ·Cancer Research ·Guillermo Peluffo,Ashim Subedee,Nicholas W. Harper,Natalie L. Kingston,Bojana Jovanović,(unknown),Laura E. Stevens,Francisco Beça,Anne Trinh,Chandra Sekhar Reddy Chilamakuri,Evangelia K. Papachristou,Katherine C. Murphy,Ying Su,Andriy Marusyk,Clive S. D’Santos,Oscar M. Rueda,Andrew H. Beck,Carlos Caldas,Jason S. Carroll,Kornélia Polyák	47
11	Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation 2019 ·Cellular and Molecular Life Sciences ·(unknown),(unknown),Felipe R. Teixeira,(unknown),Oscar M. Rueda,Jean Abraham,Carlos Caldas,Paul A. Edwards,Heike Laman	8
12	High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis 2018 ·Cancer Research ·Daniele Avanzato,Emanuela Pupo,(unknown),Claudio Isella,Giovanni Bertalot,Chiara Luise,Salvatore Pece,Alejandra Bruna,Oscar M. Rueda,Carlos Caldas,Pier Paolo Di Fiore,Anna Sapino,Letizia Lanzetti	61
13	Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts 2018 ·BMC Genomics ·Maurizio Callari,Ankita Sati Batra,R.N. Batra,Stephen‐John Sammut,Wendy Greenwood,Harry Clifford,(unknown),Suet‐Feung Chin,Alejandra Bruna,Oscar M. Rueda,Carlos Caldas	32
14	p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis 2016 ·Nature Communications ·Robert A. H. van de Ven,(unknown),Danielle Park,Robert van Domselaar,Daniëlle de Jong,Károly Szuhai,Elsken van der Wall,Oscar M. Rueda,H. Raza Ali,Carlos Caldas,P. J. van Diest,Martin W. Hetzer,Erik Sahai,Patrick W.B. Derksen	22
15	TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance 2014 ·Clinical Cancer Research ·Laxmi Silwal‐Pandit,Hans Kristian Moen Vollan,Suet‐Feung Chin,Oscar M. Rueda,Steven McKinney,Tomo Osako,David A. Quigley,Vessela N. Kristensen,Samuel Aparício,Anne‐Lise Børresen‐Dale,Carlos Caldas,Anita Langerød	215
16	A new genome‐driven integrated classification of breast cancer and its implications 2013 ·The EMBO Journal ·Sarah‐Jane Dawson,Oscar M. Rueda,Samuel Aparício,Carlos Caldas	207
17	Viviendas sociales en Vallecas, Madrid 2012 ·(unknown),Oscar M. Rueda	1
18	OC-017 TRIM44: from prognosis to therapy in oesophageal adenocarcinoma and breast cancer 2012 ·Gut ·(unknown),Nicholas B. Shannon,Pierre Lao‐Sirieix,Caryn S. Ross-Innes,Maria O’Donovan,Oscar M. Rueda,(unknown),A Noorani,Richard Hardwick,Carlos Caldas,Rebecca C. Fitzgerald	1
19	Copynumber: Efficient algorithms for single- and multi-track copy number segmentation 2012 ·BMC Genomics ·Gro Nilsen,Knut Liestøl,Peter Van Loo,Hans Kristian Moen Vollan,Marianne Brodtkorb Eide,Oscar M. Rueda,Suet‐Feung Chin,Roslin Russell,Lars O. Baumbusch,Carlos Caldas,Anne‐Lise Børresen‐Dale,Ole Christian Lingjærde	156
20	TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer 2012 ·Nature Communications ·Alejandra Bruna,Wendy Greenwood,John Le Quesne,Andrew E. Teschendorff,Diego Miranda‐Saavedra,Oscar M. Rueda,José Luís Sandoval,Ana Tufegdžić Vidaković,Amel Saadi,Paul D.P. Pharoah,Julia Stingl,Carlos Caldas	82

About Oscar M. Rueda

Oscar M. Rueda is a scholar working on Cancer Research, Oncology and Genetics, having authored 70 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (26 papers), Gene expression and cancer classification (18 papers) and Genomic variations and chromosomal abnormalities (14 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (1.7k citations) and Molecular Biology (2.4k citations). Oscar M. Rueda has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Carlos Caldas, Suet‐Feung Chin, Sarah‐Jane Dawson, Mark Dunning, Samuel Aparício, Tim Forshew, Nitzan Rosenfeld, Dana W.Y. Tsui, Davina Gale and Muhammed Murtaza. Their work appears in journals such as New England Journal of Medicine, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact